Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK

Pigment Cell & Melanoma Research
Celia J VogelDaniel S Peeper

Abstract

No effective targeted therapy is currently available for NRAS mutant melanoma. Experimental MEK inhibition is rather toxic and has only limited efficacy in clinical trials. At least in part, this is caused by the emergence of drug resistance, which is commonly seen for single agent treatment and shortens clinical responses. Therefore, there is a dire need to identify effective companion drug targets for NRAS mutant melanoma. Here, we show that at concentrations where single drugs had little effect, ROCK inhibitors GSK269962A or Fasudil, in combination with either MEK inhibitor GSK1120212 (Trametinib) or ERK inhibitor SCH772984 cooperatively caused proliferation inhibition and cell death in vitro. Simultaneous inhibition of MEK and ROCK caused induction of BimEL , PARP, and Puma, and hence apoptosis. In vivo, MEK and ROCK inhibition suppressed growth of established tumors. Our findings warrant clinical investigation of the effectiveness of combinatorial targeting of MAPK/ERK and ROCK in NRAS mutant melanoma.

References

Jun 5, 2003·Cancer Chemotherapy and Pharmacology·Masahide NakajimaTakao Kondo
Dec 18, 2004·Cancer Research·Daniel R CroftMichael F Olson
Aug 19, 2006·Molecular Cell·Yuichi J MachidaAnindya Dutta
Jun 24, 2008·Nature Reviews. Molecular Cell Biology·Antoine E Karnoub, Robert A Weinberg
Aug 18, 2009·Pigment Cell & Melanoma Research·Leisl M PackerRichard Marais
Aug 31, 2010·Cytoskeleton·Mutsuki AmanoKozo Kaibuchi
Dec 30, 2010·American Journal of Physiology. Endocrinology and Metabolism·Kwang-Hoon ChunYoung-Bum Kim
Jan 20, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aidan G GilmartinSylvie G Laquerre
May 3, 2011·Trends in Biochemical Sciences·Michelle C MendozaJohn Blenis
May 20, 2011·Pigment Cell & Melanoma Research·Yongmei FengGary G Chiang
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Oct 4, 2011·Trends in Molecular Medicine·Zhenyu JiHensin Tsao
Jan 21, 2012·Pigment Cell & Melanoma Research·Vijay WaliaYardena Samuels
May 3, 2012·Genes & Development·Liesbeth C W VredeveldDaniel S Peeper
Dec 4, 2012·Nucleic Acids Research·Juan Antonio VizcaínoHenning Hermjakob
Dec 5, 2012·Nature Reviews. Genetics·A F Maarten AltelaarAlbert J R Heck
Jan 12, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dennie T FrederickJennifer A Wargo
Feb 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Christian PoschSusana Ortiz-Urda
Aug 29, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lin ZhouKaichun Wu
Sep 24, 2013·Lancet·Alexander M M EggermontCaroline Robert
Aug 19, 2014·Pigment Cell & Melanoma Research·Vito W RebeccaKeiran S M Smalley
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertDirk Schadendorf
Dec 30, 2014·Molecular Systems Biology·Marjon A SmitDaniel S Peeper

❮ Previous
Next ❯

Citations

Feb 14, 2016·Biochemical and Biophysical Research Communications·Meng LiHua Du
Jan 5, 2016·Archivum Immunologiae Et Therapiae Experimentalis·Lei WeiJianjian Shi
Mar 19, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ha Linh Vu, Andrew E Aplin
May 11, 2016·The Journal of Investigative Dermatology·Christian PoschSusana Ortiz-Urda
Dec 20, 2016·Oncogene·I ZandvakiliY Zheng
Feb 15, 2017·The FEBS Journal·Imanol Arozarena, Claudia Wellbrock
Jul 19, 2017·Therapeutic Advances in Medical Oncology·Amélie BoespflugLuc Thomas
Mar 15, 2018·International Journal of Molecular Sciences·Giuseppina BarutelloFederica Riccardo
Mar 1, 2016·Melanoma Management·Russell W Jenkins, Ryan J Sullivan
Apr 29, 2019·Archives of Pharmacal Research·Mee-Hyun LeeJung-Hyun Shim
Oct 20, 2020·Frontiers in Cell and Developmental Biology·Cheila BritoMarta Pojo
Jun 8, 2021·Cancer Treatment Reviews·Tijana RandicStephanie Kreis
Jun 27, 2021·British Journal of Cancer·Oscar MaiquesGilbert O Fruhwirth
Jun 18, 2021·OncoTargets and Therapy·Alejandro Garcia-AlvarezEva Muñoz-Couselo
Sep 21, 2021·Physiological Reviews·Eva Crosas-MolistVictoria Sanz-Moreno

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Related Papers

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
Robert Zeiser
Pigment Cell & Melanoma Research
Michelle Dang, Leonard I Zon
Expert Opinion on Pharmacotherapy
April K S Salama, Kevin B Kim
© 2022 Meta ULC. All rights reserved